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CASE REPORT
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SUMMARY
Primary neoplasms of the respiratory tract are rarely
encountered in the paediatric population. Inﬂammatory
myoﬁbroblastic tumour (IMT) is a rare soft tissue
mesenchymal tumour but a distinct disease entity
accounting for less than 1% of all primary lung tumours.
We report a case of a 10-year-old boy who presented
with respiratory failure and left lung collapse. On ﬂexible
ﬁberoptic bronchoscopy, a pedunculated mass in the
lower part of the trachea originating from the left main
stem bronchus was identiﬁed. The patient subsequently
underwent a left-sided pneumonectomy with complete
resection of the mass. The histopathological analysis was
consistent with IMT. Two years of follow-up and the
patient remains well.
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Primary neoplasms of the respiratory tract are
rarely encountered in the paediatric population.1
Inﬂammatory myoﬁbroblastic tumour (IMT) is a
rare soft tissue mesenchymal tumour but a distinct
disease entity accounting for less than 1% of all
primary lung tumours.2 Although it has a higher
propensity to affect children and young adults, it
can occur at any age group.3–5 The ﬁrst case was
reported to be in the lung by Brunn6 but since
then, IMT has been identiﬁed to affect a wide
range of anatomical locations including the liver,
spleen, pancreas, bladder, larynx, tongue, breast,
retroperitoneum and central nervous system.3
Multiple terms have been used to describe IMT
in the past including inﬂammatory pseudotumour,
histiocytoma, plasma cell histiocytoma complex,
plasma cell granuloma, ﬁbrohistiocytoma, xanthomatous granuloma, spindle cell pseudotumour and
inﬂammatory ﬁbrosarcoma (IFS).7 8 However, the
term IMT was coined around two decades ago
owing to its distinctive pathological and molecular
features.7 Although these tumours were initially
regarded to be benign and non-neoplastic, it is now
widely accepted that these tumours may have a tendency to grow aggressively leading to local invasion
to adjacent organs, recurrence and distant
metastasis.5 9
Because of its rarity and ability to mimic other
malignant tumours on gross appearance and clinical
and radiological features, IMT can be a diagnostic
challenge to a physician. It is hence, imperative for
the histopathologists to be aware of this condition.
We report a case of a previously healthy
10-year-old boy who was diagnosed to have IMT of
the left main bronchus and was successfully treated
by pneumonectomy.
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CASE PRESENTATION
A 10-year-old boy presented to our emergency
room (ER) with a 6-month history of productive
cough, difﬁculty in breathing and a weight loss of
5 kg. Owing to the endemicity of tuberculosis (TB)
in our region, he was being treated for pulmonary
TB since 3 months by a general practitioner
without any clinical or radiological improvement.
Medical and family history of the patient was insigniﬁcant. There was no history of TB contacts.
On initial examination in the ER, the child was
in obvious respiratory distress with a respiratory
rate of 30 breaths/min, oxygen saturation of 85%
on room air, heart rate of 120/min and blood pressure of 120/78 mm Hg. There was no clubbing or
cyanosis. The respiratory system examination
revealed an asymmetric chest rise, dull percussion
note and absent breath sounds on the left side. Rest
of the systemic examination was within normal
limits.

INVESTIGATIONS
An arterial blood gas was performed which
revealed a pH of 7.43, PaCO2 39.9 mm Hg and a
PaO2 55.9 mm Hg. The chest X-ray showed nearcomplete opaciﬁcation of the left hemithorax with
a mediastinal shift to the affected side (ﬁgure 1).
Ultrasound of the chest was then performed which
did not show any pleural effusion on either side.
Subsequently, CT scan of the chest was ordered
which conﬁrmed a left lung collapse with ipsilateral
mediastinal shift and no pleural effusion or
lymphadenopathy.
A provisional diagnosis of left lung collapse and
respiratory failure was made and the child was
admitted to the paediatric intensive care unit. He
was initially started on broad spectrum antibiotics
and kept on non-invasive ventilation. There was a
suspicion of an endobronchial lesion-like foreign
body or neoplasm. He subsequently underwent a
ﬂexible ﬁberoptic bronchoscopy which revealed a
pedunculated mass in the lower part of the trachea
originating from the left main stem bronchus
almost completely occluding the lumen. The
bronchoalveolar lavage was not taken as mass was
occluding the proximal airway and patient was
unstable. An emergent surgery consult was hence
obtained for the resection of the lung mass.

DIFFERENTIAL DIAGNOSIS
The initial differential diagnoses were of left lung
pneumonia, foreign body, endobronchial TB and
tumour leading to postobstructive atelectasis.
However, after visualisation of a pedunculated
1
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Figure 3 Positive immunohistochemical staining (brown) for
anaplastic lymphoma kinase protein in lesional cells (high
magniﬁcation: ×40).
Figure 1 A chest X-ray showing left lung opaciﬁcation and volume
loss.
mass through ﬂexible ﬁberoptic bronchoscopy, the diagnostic
possibilities had narrowed down to a neoplasm and surgery was
planned consequently.

TREATMENT
The patient successfully underwent left pneumonectomy with
complete resection of the mass. On gross examination, the mass
was grey white in colour and homogenous measuring
3×2×1.5 cm. Hisotopathological analysis revealed a spindle cell
neoplastic lesion arranged in fascicles admixed with numerous
plasma cells and lymphocytes (ﬁgure 2). The neoplastic cells
had oval nuclei, inconspicuous nucleoli and eosinophilic cytoplasm. Immunohistochemical staining showed positivity for
α-smooth muscle actin (ASMA), anaplastic lymphoma kinase
(ALK) protein and desmin (ﬁgure 3). In contrast, the tumour
cells were not reactive to cytokeratin AE1/AE3 and S-100.
A diagnosis of IMT was made.

OUTCOME AND FOLLOW-UP
The patient was extubated within 24 h of surgery. He remained
well during his stay in the hospital and was discharged home on
the ﬁfth postoperative day. At 2 years of follow-up, the patient
is doing well without any relapse or complications.

Figure 2 H&E stained section showing intricate admixture of lesional
spindle and inﬂammatory cells (high magniﬁcation: ×40).
2

DISCUSSION
IMT is a rare soft tissue mesenchymal tumour, the aetiology of
which still remains unknown. It has been postulated that
patients might have a recent respiratory tract infection triggering
the inﬂammatory response which has been found in almost 30%
of the cases.10 On the contrary, some studies suggest that IMT
might be a true neoplasm due to a mutation on chromosome
2p23 leading to the over-expression of the ALK protein resulting in increased cell proliferation, initially found in anaplastic
large cell lymphomas.11 Owing to the varying nomenclature,
the incidence of IMT has been difﬁcult to calculate; however, it
has been estimated to comprise less than 1% of all primary lung
tumours.2 It is more likely to affect the paediatric population
and young adults without any gender predilection. The lung is
recognised to be the most common organ involved but IMT can
virtually affect any organ and site in the body with the abdomen
and pelvis being the most common extrapulmonary manifestations.3–6
The patients may present with a wide spectrum of symptoms
including the focal respiratory symptoms (shortness of breath,
chest pain, non-resolving cough, hemoptysis) as well as the nonspeciﬁc systemic symptoms (fever, chronic fatigue, weight loss)
attributed to the raised inﬂammatory markers such as interleukin 6 in the body.3–6 In rare cases, patients have been reported
to have arthalgia and clubbing of the ﬁngers which got resolved
after resection of the tumour.4 However, patients might also be
asymptomatic and the tumour may be found incidentally on
imaging or direct visualisation through bronchoscopy.4 Our
patient presented with symptoms of non-resolving cough and
severe respiratory distress and was found to have complete atelectasis of the left lung which has been rarely reported
before.10 12
Owing to its diverse clinical, gross and radiological manifestations, IMT can mimic malignant tumours and can be a diagnostic dilemma for physicians. The CT scan and MRI are useful in
localising the lesion in the respiratory tract. Most commonly, a
solitary well-circumscribed lesion is found in the periphery
ranging between 1.5 and 14 cm.13 Endobronchial masses, as in
our case, are much rarer. In our case, the mass could not be
identiﬁed on imaging and was visualised on ﬂexible
bronchoscopy.
Histopathological analysis remains the cornerstone for diagnosing IMT and exclusion of malignancy. Characteristically,
IMT is composed of myoﬁbroblastic spindle cells with a
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prominent inﬂammatory inﬁltrate in the background comprising
plasma cells, lymphocytes, histiocytes, eosinophils and neutrophils. It has been subjected to multiple terminologies depending
on the predominant cell type involved while the term pseudotumour denotes its potential to mimic invasive malignant
tumours.3–8 Matsubara et al14 used the term inﬂammatory pseudotumour and classiﬁed it into three histological subtypes: (A)
organising pneumonia with resolving alveolar exudates, (B)
ﬁbrous histiocytoma with lymphocytic aggregation and (C) lymphoplasmocytic type involving the aggregation of the plasma as
well as lymphocyte cells (as in our case). Immunohistochemical
staining reveals positivity for ALK protein in almost 50% of the
cases (as in our case). Alterations with ALK are more likely to
be reported in the pulmonary and abdominal IMTs. Although
ALK positivity has been found to be associated with a higher
chance of local recurrence, ALK negativity has a poorer
outcome associated with a greater risk of distant metastasis.11
Initially thought to be a benign lesion, IMT is now considered
to have a more aggressive nature having a tendency of local
invasion to adjacent organs, recurrence and rarely malignant
transformation and metastases.3 Carillo et al5 and Gallego et al9
have reported cases of IMT of the lung with adrenal gland and
maxillary metastases, respectively. The term, IFS has been utilised to classify these tumours with aggressive nature and
metastases.3 9
Surgical resection remains the diagnostic and therapeutic
modality of choice. It has been reported that transthoracic or
transbronchial needle biopsy may not be deﬁnitive and it may
be difﬁcult to differentiate between IMT and other neoplasms
including ﬁbrohistiocytic neoplasms, nodular sclerosing
Hodgkin lymphoma, primary lung cancer and mediastinal ﬁbrosis.2 Therapeutically, complete surgical resection, has shown to

have excellent prognosis and low rate of recurrence.3 4 10 13 In
cases where resection is not possible, use of lasers, steroids and
non-steroidal anti-inﬂammatory drugs have shown some
promise.15 16 Recently, the potential role of crizotinib, a competitive inhibitor of ALK tyrosine kinase has been highlighted in
treating ALK-positive IMTs.17 This report describes the case of a
patient with IMT exhibiting ALK rearrangement, who achieved
substantial response to crizotinib despite considerable tumour
burden. On the contrary, another patient with ALK negative
IMT, failed to show an improvement on crizotinib, hence enforcing the role of ALK-dependent signal transduction in a subgroup of patients with IMT.17
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tissue tumour that can present as an endobronchial lesion
leading to atelectasis and respiratory failure.
▸ Although IMT was initially regarded to be benign and
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